Back to search
FDAFDA · Food and drugs·Recall number D-126-2013

Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane Laboratories Inc., Columbus, OH 43216, NDC 0054-0112-25.

Published January 23, 2013 · Recall initiated: December 12, 2012

Summary

FDA records drug Class III recall D-126-2013, published January 23, 2013 and initiated December 12, 2012. Recalling firm: Boehringer Ingelheim Roxane Inc; Status: Terminated; Reported quantity: 3,553 bottles; Lot: Lot #160017A, Exp 04/2013. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Impurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boehringer Ingelheim Roxane Inc
Distributor
Nationwide
Lot
Lot #160017A, Exp 04/2013.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane Laboratories Inc., Columbus, OH 43216, NDC 0054-0112-25. recalled?

Yes. FDA published recall D-126-2013 on January 23, 2013. Reported hazard: Impurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.

What should I do if I have this product?

Voluntary: Firm initiated · Letter